Stockreport

Acorda Provides Update on Tozadenant Development Program

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF Identified cases of agranulocytosis, possibly drug-related, in some cases associated with sepsis and death Increased blood cell c [Read more]